140 results
Page 2 of 7
8-K
EX-99.1
zi99ivsoi8
11 May 23
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates
4:06pm
PRE 14A
cs7gt8 e72etz0i37g
31 Mar 23
Preliminary proxy
4:02pm
8-K
EX-99.1
8z9v0
23 Dec 22
Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement
4:11pm
425
7si5gouknnh lyzjmd
14 Dec 22
Business combination disclosure
9:56pm
8-K
zgtvahi2 19p
14 Dec 22
Other Events
9:49pm
425
ocda0iuis
6 Dec 22
Business combination disclosure
4:53pm
425
hk1ekz
6 Dec 22
Business combination disclosure
7:02am
8-K
EX-99.2
tb73zhw
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
EX-99.1
dqiuuf1
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
1p0ajx
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
425
5fdz tdeqpe559y9
14 Nov 22
Business combination disclosure
4:20pm
8-K
EX-99.1
98pedjlifxv
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
4x53cofpza
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
1tj09
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
bv6t4z9a
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
dex1swyf7v 5tn7
28 Sep 22
Business combination disclosure
6:01am
425
18jao
27 Sep 22
Business combination disclosure
9:30am